Research Article

 

Characterization of Ulva fasciata Ethanolic Extract-mediated Biosynthesized Silver Nanoparticles and Evaluation of their Nephrocadiopreventive Effects in Doxorubicin-injected Wistar Rats

 

Asmaa M. Mahmoud1, Basant M. Mohamed1, Ibraheem B.M. Ibraheem2, Hanan A. Soliman1, Osama M. Ahmed3*

1Biochemistry Department, Faculty of Science, Beni-Suef University, P.O. 62521, Beni-Suef, Egypt; 2Botany and Microbilogy Department, Faculty of Science, Beni-Suef University, P.O. 62521, Beni-Suef, Egypt; 3Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, P.O. 62521, Beni-Suef, Egypt.

 

Received | May 31, 2020; Accepted | August 15, 2020; Published | September 20, 2020

*Correspondence | Osama M. Ahmed, Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, P.O. 62521, Beni-Suef, Egypt; Email: [email protected]; [email protected]

Citation | Mahmoud AM, Mohamed BM, Ibraheem IBM, Soliman HA, Ahmed OM (2020). Characterization of Ulva fasciata ethanolic extract-mediated biosynthesized silver nanoparticles and evaluation of their nephrocadiopreventive effects in doxorubicin-injected wistar rats. Adv. Anim. Vet. Sci. 8(s2): 98-111.

DOI | http://dx.doi.org/10.17582/journal.aavs/2020/8.s2.98.111

ISSN (Online) | 2307-8316; ISSN (Print) | 2309-3331

Copyright © 2020 Mahmoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

Introduction

 

Doxorubicin (Adriamycin) is an anthracycline anticancer drug that is commonly applied for the chemotherapy of solid and hematological tumors such as breast cancer, soft-tissue sarcomas, osteosarcomas, leukemia and lymphomas (Cappetta et al., 2017). However, its clinical use may be restricted due to its severe toxicological history in various organs including kidneys and heart (El-Sherbiny and ElSherbiny, 2014; Pugazhendhi et al., 2018; Mohajeri and Sahebkar, 2018; Zhao et al., 2018a). Several studies have indicated that doxorubicin-mediated toxicity is a result of oxidative stress, DNA damage, lipid peroxidation, apoptosis and induced autophagy and mitochondrial injury (Zhao et al., 2018b). Many other publications reported nephrotoxicity and cardiotoxicity effects of doxorubicin in experimental animals (Ahmed et al., 2017; Kaiserová et al., 2017; Nagai et al., 2018; Ahmed et al., 2019, 2020). These publications stated the crucial implication of oxidative stress and antioxidant defense system in inducing the nephrocardiotoxicities. Based on these findings, the use of natural antioxidant or green biosynthesized nanoparticles that enhance the antioxidant efficiency of bioactive ingredients may suppress or abrogate the side effects and toxicity of the chemotherapeutic drugs like doxorubicin.

 

Silver nanoparticles (AgNPs) are of great significance to biomolecular catalysis, electron transfer and oxygen transportation as a result of the reaction with amino acids and proteins as the main targets of medicines in the organisms (Wang et al., 2007; Cai et al., 2010). Nowadays, AgNPs has efficient biological action due to its physicochemical property in which larger surface to volume ratio resulted into higher surface exposure (Nadhe et al., 2019). Green synthesis of AgNPs using plants and algae are ecofriendly procedures without need to the use of high-cost and toxic chemicals (Javaid et al., 2018; Nadhe et al., 2019). Marine algae have valuable contents such as polysaccharides (alginates, laminarians and fucans) and other pharmaceutical and nutraceutical compounds (Rahimi et al., 2014). They were used to mediate reduction of silver into AgNPs (Anand and Mandal, 2015). The green macroalga, U. fasciata, had potent therapeutic value and it was used for synthesis of AgNPs (Rao and Boominathan, 2015). AgNPs synthesis by U. fasciata had toxic effects against cancer (El Bialy et al., 2017; Hamouda et al., 2019) and very high antibacterial activity (Rao and Boominathan, 2015).

 

U. fasciata Delile, which belongs to phylum Chlorophycota, class Ulvophyceae, order Ulvales and family Ulvaceae (Valeem and Shameel, 2006), is a dark green or bright grass green in colour and may be colorless under stressed conditions. The Thallus is thin and sheet like, consist of broad blades, basal portion 10-15 cm wide, tapering at the base, up to 15 cm lengthy, broad at the base and joint, but upper part is divided deeply into many ribbon like segments, margin soft, often undulate and holdfast is small. U. fasicata has shown antioxidant (Kokilam and Vasuki, 2014), antileishmanial (Sabina et al., 2005), hypoglycemic (Subash-Babu et al., 2008; Abirami and Kowsalya, 2015), antibacterial (Selvin et al., 2004; Shahnaz and Shameel, 2006), antifungal (Langeswaran et al., 2019), nematicidal and insecticidal activities (Valeem et al., 2011).

 

Therefore, the present study used U. fasciata ethanolic extract for biogenic synthesis of AgNPs and aimed to assess the antagonistic effects of the U. fasciata ethanolic extract and its biogenic AgNPs on doxorubicin-induced renocardiotoxicities in Wistar rats.

 

MATERIALS AND METHODS

 

Alga collection and isolation

U. fasciata was collected on March 2014 from the shallow water beside of the Mediterranean Sea shores at Abo Qir coast, Alexanderia, Egypt. The identification and taxonomy of the seaweed samples was carried out by Prof. Dr. / Borie M. Ibraheem (Professor of Microbiology, Botany and Microbiology Department, faculty of science, Beni-Suef university, Egypt).

 

Preparation of algal extract

The collected alga was washed with marine water, then with tap water and finally with distilled water. The washed alga was blotted, spread out and dried in good aerated shade area at room temperature for two weeks. Shade dried sample was ground to fine powder by an electric grinder. The powdered sample was stored in sterilized containers for further usage. Powdered sample of U. fasciata (100 g) were extracted with 400 ml of absolute ethyl alcohol for 6–8 hours (hrs) in Soxhlet apparatus (500 mL boiler). At the end of extraction, the alga debris in extract was filtered out and the ethanol in the extract was evaporated to viscous semi-solid residues in a vacuum at 35 ᵒC using a rotatory evaporator. At the end, the dried extract was stored at 4 ᵒC for pending its use for analysis and treatment.

 

Synthesis of AgNPs

It was done by adding 10 ml of U. fasciata ethanolic extract to 90 ml of 1 mM of AgNO3 at room temperature. At once, the color changed to greenish yellow color on mixing of AgNO3 solution to algal extract. Then, the color changed bit by bit until it became dark brown color which indicated the formation of AgNPs (Ibraheem et al., 2016).

 

Characterization of synthesized AgNPs

Visual characterization

Biosynthesis of AgNPs was verified by observation of the developed color in the reaction as a result of the algal extract with 1 mM AgNO3 solution in comparison with the control. The color changed from pale yellow to brown indicating the biogenesis of AgNPs. The biogenic AgNPs were obtained by centrifugation at 12000 r.p.m. for 10 min. The pellets were washed twice with distilled water. This protocol was repeated thrice. Afterthat, the AgNPs pellets were lyophilized for further uses.

 

Ultra Violet–Visible (UV-Vis) spectroscopy analysis

The UV-spectroscopy of biogenic AgNPs was examined according the methods of Swamy et al. (2015), Abdel-Raouf et al. (2017) and Hamed et al. (2017).

 

Transmission Electron Microscopy (TEM) analysis of AgNPs

The morphological analysis of the NPs was achieved by TEM according to the methods of Abdel-Raouf et al. (2017), Hamed et al. (2017) and Hamouda et al. (2018).

Characterization analysis of U. fasciata extract

Fourier transform infrared analysis (FTIR)

FTIR was used to identify the possible biomolecules responsible for the reduction of the Ag ions and capping of the bioreduced AgNPs synthesized by U. fasciata extract according to the method of Hamed et al. (2017).

 

Gas Chromatographic/Mass Spectrometric (GC-MS) Analysis

GC-MS analysis was performed according the methods of Rodeiro et al., (2015).

 

Chemicals

Doxorubicin (Adriblastina) was obtained from Carlo Erba, Turkey in the form of 10 mg/ampoule. Silver nitrate (AgNO3) and absolute ethyl alcohol was obtained from Sigma Chemicals Company, St. Louis, MO, USA. All other chemicals used for the investigation were of analytical grade and were commercially obtained.

 

Experimental animals

Male rats of Wistar strain, weighing between 100-120 g and aging 9-11 weeks, were used in the present investigation. They were obtained from the Animal House of Abou Rawash, El-Giza, Egypt. They were maintained under strict care and observation for 2 weeks before the starting the experiment to exclude any intercurrent infection. The chosen animals were housed in polypropylene cages with good aerated stainless steel covers at temperature of 25±5ºC and normal 12-hours daily light-dark cycle. The rats were supplied with access of water and standard balanced diet ad libitum. All animal procedures were approved by the Experimental Animal Ethics Committee, Faculty of Science, Beni-Suef University, Egypt (Ethics approval number: BSU/FS/2017/18).

Doses and treatment

The animals were injected with doxorubicin by an intraperitoneal route (i.p.r.) in a dose level of 2.5 mg/kg b. wt three days/week for 6 weeks. The doxorubicin was dissolved in 0.9 % NaCl (Kabel et al., 2018; Pugazhendhi et al., 2018). The dose of U. fasciata and AgNPs of U. fasciata used in this study was 100 mg/kg b. wt (Margret et al., 2009) which was given 3 times per week by oral gavage for 6 weeks. They were dissolved in 1% CMC as a vehicle at concentration 100 mg U. fasciata and AgNPs/U. fasciata/5 ml 1% CMC.

 

Experimental design

Forty rats were used in the present study. These rats were divided into 4 groups (n = 10) designed as follow:

Group 1 (Normal control): The rats within this group were supplemented with the equivalent volume of vehicles 0.9% NaCl by i.p.r. and 1% CMC 3 times/week by oral gavage for 6 weeks.

Group 2 (Doxorubicin–injected control): The rats within this group were injected with doxorubicin in a dose level of 2.5 mg/kg b. wt by i.p.r. 3 times/week for 6 weeks.

Group 3 (Doxorubicin-injected rats treated with U. fasciata extract: The rats within this group were injected with doxorubicin in a dose level of 2.5 mg/kg b. wt by i.p.r. 3 times/week for 6 weeks and were orally treated with algal extract in dose level of 100 mg/kg b. wt 3 times/week by oral gavage for 6 weeks.

Group 4 (Doxorubicin-injected rats treated with U. fasciata AgNPs: The rats within this group were injected with doxorubicin in a dose level of 2.5 mg/kg b. wt. by i.p.r. 3 times/week for 6 weeks and were orally treated with U. fasciata AgNPs at dose level of 100 mg/kg b. wt. 3 times/ week by oral gavage for 6 weeks.

 

Sampling and tissue preparation

By the end of the experiment, six animals of normal, doxorubicin-injected control rats and doxorubicin-injected rats treated with U. fasciata and U. fasciata biosynthesized AgNPs were sacrificed under mild diethyl ether inhalation anesthesia. Blood samples were collected from jugular vein in serum-separating gel and clot activator tubes. Tubes containing blood were centrifuged at 3000 rpm. at 30 ºC for 15 minutes and sera were aspirated into Eppendorf tubes. The sera were frozen at -30ºC pending biochemical analyses. Kidney and heart from each animal were rapidly dissected out and were perfused in sterile saline. One kidney and one half of heart were fixed in neutral buffered formalin for 24 hours and then transferred into 70% alcohol for histopathological examination. The other kidney and the half of heart were separately homogenized into 0.9% sterilized NaCl (10% w/v) by Teflon Homogenizer (Glas-Col, Terre Haute, USA).

 

Biochemical analyses

Creatinine levels in sera were assayed based on the procedure of Henry (2001) using the reagent kits obtained from Diamond Diagnostics, Egypt. Urea levels in sera were detected based on the procedure of Vassault et al. (1986) using the reagent kits purchased from Biomed Diagnostics, Egypt. Uric acid levels in sera were estimated based on the method of Tiffany et al. (1972) by reagent kits purchased from spectrum Company, Egypt. Creartine kinase-MB (CK-MB) activity was assayed by kinetic method using kits developed by Spectrum Diagnostics, Egypt based on the method of Friedman and Young (1997). Aspartate aminotransferase (AST) activity in serum was detected by kinetic method according to the method of Burtis et al. (2005) using reagent kits obtained from BioSystem Company (Spain). Lactate dehydrogenase (LDH) activity in serum was estimated by kinetic method according to the method of Witt and Trendelenburg (1982) using reagent kits purchased from Human (Germany).

 

Kidney and heart GSH (glutathione) contents were quantified based on the method of Beutler et al. (1963). Liver lipid peroxidation was quantified in kidney and heart by measuring manlondialdehye (MDA) production based on the procedure of Preuss et al. (1998). GST (glutathione-S-transferase) activities in kidney and heart were detected base on the publication of Mannervik and Gutenberg (1981). GPx (glutathione peroxidase) activities in kidney and heart were determined based on Tappel (1978).

 

Histopathological studies

Fixed kidney and heart tissues samples were transported to Pathology department, NCI (National Cancer Institute), Cairo University, Egypt for processing and staining of 5µm thick sections with hematoxylin and eosin (H and E) for histopathological examination.

 

Statistical analysis

Data are represented as mean ± standard error mean (SEM). Analysis of variance (one way-ANOVA) was used to identify statistically significant differences between groups. One way-ANOVA was followed by least significant difference (LSD) to compare various groups at P<0.05. All statistical analyses were performed using SPSS 15.0 software.

 

RESULTS AND DISCUSSION

 

Characterization of synthesized AgNPs and identification of chemical constituents of the extract

Visual characterization

Before adding alga ethanolic extract to AgNO3 solution, algae extract had green color and AgNO3 solution was colorless. After addition of the alga extract to AgNO3 solution, the color gradually changed to dark brown (Figure 1). At once after addition, the color changed to yellow and by the time, it changed to the dark brown color which indicated the formation of AgNPs (Figure 2).

 

Reduction of AgNO3 was visually evidenced by the color change (colorless to brownish yellow) of reaction mixture after 3 minutes of reaction (Figure 2). The increase in the intensity of brown color is in direct proportional to the period of incubation. The change in color to brown may be attributed to the excitation of surface plasmon resonance (SPR) effect and reduction of AgNO3 (Mulvaney, 1996). Also, the time taken for AgNPs formation is very fast (less than 3 minutes). These results agree with Rajeshkumar et al. (2012) and Abdel-Raouf et al. (2013) who reported that the appearance of dark brown color in solution. Also, Ajitha et al. (2015) reported the formation of AgNPs in a few minutes. Otherwise, Bhimba et al. (2014) and Devi and Bhimba (2014) suggested the time formation of AgNPs 10 minutes at 121ºC. In disagreement with the present study, Rahimi et al. (2014) reported that the formation of AgNPs took long time Furthermore, Parveen and Lakshmi (2016) reported that in the biosynthesis of AgNPs using red alga, Amphiroa fragilissima, the time of reduction of AgNO3 was 20 minutes while in the current work, the algal NPs recorded high stability and formed within short time.

 

 

 

UV-visible spectroscopy analysis

The formation of AgNPs was confirmed by changes in color followed by UV-Visible spectrophotometric analysis which has been shown to be a very useful technique for the analysis of some metal NPs.

 

The biogenesis of AgNPs was confirmed by a UV-Visible spectral scan at a wavelength ranged from 200 to 800 nm. SPR spectrum of AgNPs produced by using U. fasciata ethanolic extract depicted a distinct absorption peak at 210 nm and the other at 659.50 nm (Figure 3) that prove the presence of AgNPs. Brause et al. (2002) demonstrated that optical absorption spectra of metallic NPs is predominantly dominated by SPR and the peak of absorption correlated with particle size. SPR peak of AgNPs in aqueous dispersion shifts to longer wavelengths with increase in particle size. The position and shape of plasmon absorption of AgNPs depend on many indices including particle size, shape and the dielectric constant of the reaction medium as well as particles adsorbed on surfaces of AgNPs (Krishnaraj et al., 2010).

 

 

FT-IR analysis

FT-IR spectroscopy measurements were performed to recognize the possible biomolecules found in U. fasciata ethanolic extract which are responsible for reduction and capping of AgNPs.

 

FT-IR spectrum (Figure 4) shows the molecular configuration of different functional groups present in ethanolic extract of U. fasciata showed bands at 3391.661 (cm-1) assigned to N-H stretche, at 2932.978 (cm-1) assigned to C-H Stretch, at 2385.984 (cm-1) assigned to P-H, at 2270.329 (cm-1) assigned to N=C=O, at 1644.523 (cm-1) assigned to C=C group, at 1429.147(cm-1) assigned to C=C group, at 1103.149(cm-1) assigned to C-O group and at 626.527(cm-1) assigned to C-Cl group. These stretched bands refer to presence of some functional groups such as 1ry and 2nd amine and amide, alkane, phosphine, isocyanate, alkene, aromatic, alcoholic and alkyl halide, respectively. Similar findings pertaining to other marine algea were reported earlier by several other researchers (Manilal et al., 2010; Anbarasan et al., 2013; Trivedi et al., 2013; Ibraheem et al., 2016; Zaid et al., 2016; Khatri et al., 2017).

 

 

The main band at 3391.661 (cm-1) assigned to 1ry, 2nd amine and amide N-H stretched band and this indication for protein prescence. Proteins most possibly could form a coat cover of the metal NPs (i.e., capping of AgNPs) to prevent agglomeration of the particles and stabilizing in the medium (Sahayaraj and Rajesh, 2011). Also, proteins represent another important utility of this feedstock as a potential source of proteinaceous diet (Wassef et al., 2013). Also, U. fasciata contains other bands such C-H, C=C and C-O. These groups showed for presence of polysaccharide, carbohydrates of monosaccharide and biological molecules such as secondary metabolites found on marine algae (Sahayaraj and Rajesh, 2011; Shiny et al., 2013). These groups could possibly play important role in the synthesis and stabilization of metal NPs.

 

TEM analysis of AgNPs

TEM of AgNPs analysis, measurement was applied to characterize the NPs size and morphology. TEM micrographs of representative AgNPs synthesized by U. fasciata ethanolic extract are shown in Figure 5. These results showed that U. fasciata ethanolic extract strongly affected the size and shape of the AgNPs weren’t uniform in size and shape. The NPs were large and small spherical particles and small percentages of rod. TEM analysis of particles size also showed maximum particles in size 2 to 200 nm.

 

 

TEM has provided further insight into the size details and the morphology of the biosynthesized AgNPs. TEM images and histograms of particle size distribution recorded from AgNPs solutions are shown in Figure 5. It is observed that the biogenic NPs are polydispersed and predominantly spherical in shape (Dhas et al., 2014) with maximum diameter size of 200 nm. All the nanoparticles are well separated and no agglomeration was observed (El-Rafie et al., 2013). Bioorganic materials bound to the nanoparticles surfaces which are responsible for the stability of nanoparticles (Amaladhas et al., 2012).

 

Table 1: GC-Mass analysis.

 

Read time (RT min)	Chemical compound	Nature of compound	Peak area %	Biological activity
3.285	Cabamic acid, methyl ester (urethylane)	Ester	1.61%	Antiparasitic activity and antifungal
3.675	Furfural (2-furanecarboxyldhyde)	aldehyde	2.20%	Mutagenic and anticarcinogenic
4.374	Sulfonylbismethane (DMSO) (Dimethulsulfoxide)	organosulfur compound	20.87%	anti-inflammatory antioxidant and
7.192	1-Ethyl-4-methylbenzene (toluene)	Aromatic	0.7%	Antioxidant
10.185	Methyl-2-butenylether	Flavonoids	0.58%	Antimalarial
11.780	Dodecane (Bihexyl)	alkane hydrocarbon	0.34%	Antimicrobial
15.244	Cyclohexasiloxane (Dodecamethyl-CAS)	Cosmetic	0.37%	Antimicrobial
17.055	Tetradecane (Isotetradecane)	Iodo (alkane)	0.81%	Antimicrobial
20.455	(7aR)-5,6,7,7a-Tetrahydro-4,4,7atrimethyl (2(4H)-benzofuranone)	Terpenes	1.43%	antimicrobial activities
21.852	Hexadecane (n-cetane)	Hydrocarbon	1.29%	Antiviral and antimicrobial
23.628	8-heptadecene (Heptadec-8-ene)	Alkene	3.31%	antimicrobial and antibacterial
24.688	Tetradecanoic acid (Myristic acid)	Fatty acid	0.18%	Antimicrobial and antimalarial
25.972	Loliolide	Monoterpene lactone	1.00%	antioxidant, ANT-REPELLENT, antimicrobial
26.184	Octadecane (n-octadecane)	Alkane	0.58%	antimicrobial and antioxidant antibacterial
28.356	Hexadecanoic acid methyl ester (methyl palmitate)	Fatty acid methyl ester	11.03%	Anti-oxidant, decrease blood cholesterol, anti-inflammatory
39.447	1,2 Benzene dicarboxylic acid dibutyl ester (di,2-ethylhexyl-phthalate)	Ester	0.38%	Antimicrobial, antifungal, anti-malarial
24.688	Tetradecanoic acid methyl ester (methyl miristate)	Fatty acid methyl ester	0.32%	Antibacterial, antifungal
29.841	Hexadecanoic acid (CAS) (palmitic acid)	Fatty acid	11.77%	Antimicrobial Antioxidant anti-inflammatory and anti-mutagenic.
30.085	Hexadecanoic acid, ethyl ester (ethyl palmitate)	Ester of fatty acid	1.34%	Antioxidant, hypocholesterolemic nematicide, pesticide, anti androgenic flavor, hemolytic, 5-Alpha reductase inhibitor
32.056	9,12,15-Octadecatrienoic acid, (Z,Z,Z) methyl ester	Fatty acid of methyl ester	1.84%	Antiinflammatory, hypocholesterolemic cancer preventive, hepatoprotective, nematicide, insectifuge, antihistaminic antieczemic, antiacne, 5-Alpha reductase inhibitor, antiandrogenic, antiarthritic, anticoronary, insectifuge
27.017	Neophytadiene (2-hexadecene-1-ol)	Terpenes	4.51%	Antimicrobial
32.158	9-Octadecenoic acid (Z) methyl ester (methyl elaidate)	Unsaturated fatty acid methyl ester	1.31%	Antioxidant, anti cancer
27.518	2-Hexadecen-1- ol (3,7,11,15-tetramethyl-RRR- (E)-(T)- Phytol)	Terpene alcohol	4.22%	Antimicrobial anti-inflammatory anticancer diuretic
26.184	Octadecane (n-octadecane)	Alkane	0.58%	Antimicrobial
33.334	Oleic acid (9-octadeconic acid)	Fatty acid	2.62%	Antimicrobial
32.513	Octadecanoic acid methyl ester (methyl stearate)	Fatty acid methyl ester	0.73%	Antimicrobial
27.162	2-Pentadecanone (hexahydrofarnesyl acetone)	Ketone	0.67%	Antimicrobial

GC-Ms analysis of the ethanolic extract of U. fasciata

Marine macroalgae are one of nature’s most biologically active resources, as they possess multiple bioactive compounds. Compounds isolated from marine macroalgae have exerted many biological activities (Babu et al., 2014).

 

The GC-MS analysis of U. fasciata showed presence of 27 bioactive compounds; these compounds are presented in Table 1. The main compounds in this sample were DMSO with peak area (20.87%), palmitic acid with peak area (11.77%), methyl palmitate with peak area (11.03%), Neophytadiene with peak area (4.51%) and 2-Hexadecen-1- ol (3,7,11,15-tetramethyl-RRR- (E)-(T)- Phytol with peak area (4.22%). The confirmation of the presence of compounds increase the knowledge on the phytochemical composition of U. fasciata ethanolic extract and it must add to the understanding of the product pharmacological properties (Rodeiro et al., 2015). Phytochemical components including flavonoids, tannins, aromatic compounds or secondary metabolites act as defense mechanism against many microorganisms. The therapeutic properties of green algae and medicinal plants may be due to the presence of several secondary metabolites such as flavonoids, alkaloids, saponins, tannins, phenolic compounds and phytosterols (Britto et al., 2012; Khatri et al., 2017).

 

Effects on biochemical and oxidative stress parameters

The kidney is one of the main target organs subjected to toxic xenobiotics because they receive large blood flow (about 21% of cardiac output) and has a capacity to extract and concentrate toxic materials by its highly specialized cells (Azab et al., 2014). Data in Table 2 indicated that serum creatinine, urea and uric acid levels significantly (p<0.05) elevated in doxorubicin-injected rats in comparison to control group; the recorded percentage increases were 16.67%, 159.38% and 56.25%, respectively. These data are in accordance with those obtained by many authors (Yilmaz et al., 2006; Alberto et al., 2008). The increase in these parameters in serum reflects the impairment of kidney function (Varely, 1987; Bedi and Priyanka, 2012; Ahmed et al., 2017, 2019) as a result of doxorubicin intraperitoneal injection in a dose level of 2.5 mg/kg b. wt 3 times/week for 6 weeks. On the other hand, the doxorubicin-injected rats treated with U. fasciata and AgNPs/U. fasciata showed a significant decrease (p<0.05) in serum creatinine and urea levels. Thus, these results reflect the effective nephropreventive effects of both treatments in doxorubicin-injected rats. While AgNPs/U. fasciata produced a significant decrease in serum uric acid level, U. fasciata induced a non-significant effect (p>0.05) in comparison with doxorubicin-injected control. AgNPs/U. fasciata was more potent than U. fasciata extract in decreasing serum creatinine and uric acid levels. These results are agreement with Mahmoud and Hussein (2014) who demonstrated that aqueous extract of the green macroalga, Ulva lactuca, reduced the nephrotoxicity against N-nitrosodiethylamine and phenobarbital and AbdEl-Raouf et al. (2017) who reported the anti-nephrotoxicity of biogenic AgNPs synthesized by U. fasciata. In addition, BelHadj et al. (2013) had also shown that Ulva lactuca polysaccharides produced a decrease in plasma creatinine and urea levels; thus preventing kidney dysfunctions.

 

Table 3 indicated that serum CK-MB, AST and LDH activities exhibited a significant (P<0.05) increase in doxorubicin-injected rats in comparison to control group; the recorded percentage increases were 44.59%, 143.79% and 578.17% respectively as compared with corresponding normal controls. These results are in accordance with Bast et al. (2007), Ahmed et al. (2017), Chen et al. (2017), Nimbal and Koti (2018) and Ahmed et al. (2019).

 

Table 2: Effect of U. fasciata ethanolic extract and AgNPs/U. fasciata on serum creatinine, urea and uric acid levels in doxorubicin-injected rats.

 

Parameters	Creatinine (mg/dl)	% Change	Urea (mg/dl)	% Change	Uric acid (mg/dl)	% Change
Groups
Normal	0.60 ± 0.02b	-	12.80 ± 0.36a	-	1.60 ± 0.08b	-
Doxorubicin	0.70 ± 0.02c	16.67	33.20 ± 0.95c	159.38	2.50 ± 0.17c	56.25
Doxorubicin + U. fasciata	0.60 ± 0.02b	-14.29	24.50 ± 1.25b	-26.20	2.40 ± 0.09c	-4.00
Doxorubicin + AgNPs/U. fasciata	0.50 ± 0.04a	-28.57	25.10 ± 1.03b	-24.40	1.20 ± 0.09a	-52.00
LSD at the 5% level	0.04		1.44		0.15
F- probability	P<0.001		P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

Table 3: Effect of U. fasciata ethanolic extract and AgNPs / U. fasciata on serum CK-MB, AST and LDH activitie in doxorubicin-injected rats.

 

Parameters	CK-MB (U/L)	% Change	AST (U/L)	% Change	LDH (U/L)	% Change
Groups
Normal	370.00 ± 13.10a	-	44.30±2.00a	-	150.70 ± 11.90a	-
Doxorubicin	535.00 ± 9.90c	44.59	108.00±2.00d	143.79	1022.20 ± 21.50d	578.17
Doxorubicin + U. fasciata	458.70 ± 7.40b	-14.26	72.00±1.80c	-33.33	679.30 ± 31.70c	-33.55
Doxorubicin + AgNPs/U. fasciata	361.70 ± 12.0a	-32.39	66.30±1.70b	-38.61	486.30 ± 25.40b	-52.43
LSD at the 5% level	13.96		2.44		30.68
F- probability	P<0.001		P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

Table 4: Effect of U. fasciata ethanolic extract and AgNPs / U. fasciata in kidney LPO product and SOD activity in doxorubicin-injected rats.

 

Parameters	LPO (nmole MDA/100mg tissue/hour)	% Change	SOD (mU/100mg tissue)	% Change
Groups
Normal	12.70 ± 1.30a	-	6.40 ± 0.20c	-
Doxorubicin	23.70 ± 0.60c	86.61	3.10 ± 0.30a	-51.56
Doxorubicin + U. fasciata	17.30 ± 0.20b	-27.00	4.80 ± 0.10b	54.84
Doxorubicin + AgNPs / U. fasciata	13.70 ± 1.20a	-42.19	4.90 ± 0.05b	58.06
LSD at the 5% level	1.19		0.25
F- probability	P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

Table 5: Effect of U. fasciata ethanolic extract and AgNPs / U. fasciata on kidney GSH content and GPx and GST activities in doxorubicin-injected rats.

 

Parameters	GSH (nmole/100mg tissue)	% Change	GST (U/100mg tissue)	% Change	GPx (mU/100mg tissue)	% Change
Groups
Normal	38.60 ± 1.20d	-	242.70 ± 9.20c	-	205.50 ± 1.40b	-
Doxorubicin	23.30 ± 0.80a	-39.64	104.00 ± 4.30a	-57.15	166.50 ± 3.90a	-18.98
Doxorubicin + U. fasciata	28.10 ± 0.30c	20.60	164.50 ± 1.10b	58.17	173.30 ± 2.00a	4.08
Doxorubicin + AgNPs/U. fasciata	26.50 ± 0.60bc	13.73	114.30 ± 4.20a	9.90	173.80 ± 1.20a	4.38
LSD at the 5% level	1.09		7.13		3.79
F- probability	P<0.001		P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

The elevated serum CK-MB, AST and LDH activities reflect the increased leakage of these cytoplasmic enzymes from the damaged and necrotic cardiomyocytes to the blood (Farvin et al., 2004; Gürgün et al., 2008; Ahmed et al., 2017, 2019) as a result of doxorubicin cardiotoxicity. On the other hand, the doxorubicin-injected rats treated with U. fasciata and AgNPs/U. fasciata showed a significant decrease in serum CK-MB, AST and LDH activities. The treatment with AgNPs/U. fasciata was more effective than U. fasciata extract in preventing the elevation in serum CK-MB, AST and LDH activities in doxorubicin-injected rats. The decrease in these cardiac enzymes activities in serum as a result of treatment with U. fasciata and AgNPs/U. fasciata might be attributed to their capability to maintain membrane integrity, thereby restricting the leakage of these enzymes to blood. This attribution was supported by Rajadurai and Prince (2006), Zhou et al. (2006) and Zhou et al. (2008). Based on these results, it can be suggested that both U. fasciata and AgNPs/U. fasciata have potent cardiopreventive effects against doxorubicin-induced heart injury and AgNPs/U. fasciata was more potent.

 

Tables 4, 5, 6, and 7 showed the effect of U. fasciata and AgNPs/U. fasciata on the kidney and heart oxidative stress and antioxidant biomarkers in doxorubicin-injected rats. The treatment of doxorubicin-injected rats with U. fasciata and AgNPs/U. fasciata produced a remarkable increase of lowered GSH content and SOD, GST and GPx activities as compared to the corresponding doxorubicin-injected controls. In contrast, the elevated renal and cardiac LPO product in doxorubicin-injected rats significantly decreased (p<0.05) as a result of treatments with U. fasciata and AgNPs/U. fasciata which was more effective.

 

In our opinion, the enhancements in kidney and heart function and structural integrity in doxorubicin-administered rats treated with U. fasciata and AgNPs/U. fasciata may be attributed, at least in part, to the suppression oxidative stress and reinforcement of the antioxidant defense system in the kidney and heart. This suggestion is supported by the present results which revealed that U. fasciata extract and AgNPs/U. fasciata have detectable improvements effect on heart LPO product, GSH content, GST, GPx and SOD activities.

 

Effects on kidney histological changes

Photomicrographs of kidney histological sections of normal, doxorubicin-injected groups and doxorubicin-injected groups treated with U. fasciata and AgNPs/U. fasciata were shown in Figure 6 (Photomicrographs 6a-d).

 

Photomicrograph 6a showed normal histologic structure of glomeruli, proximal tubules and distal tubules. In doxorubicin-injected rats, severe glomerulonephrosis associated with severe focal inflammatory cells infiltration in the interstitial area were observed (Photomicrograph 6b). Doxorubicin-injected rats with U. fasciata showed mild degenerative changes of renal tubules and hypocellularity in the glomeruli (Photomicrograph 6c). Treatment of doxorubicn-injected rats with AgNPs/U. fasciata resulted in nearly normal histological architecture with mild inflammatory cells between renal tubules (Photomicrograph 6d).

 

 

 

In the present study, the histolopathological changes due to doxorubicin-injection in the present study showed severe glomerulonephrosis and severe inflammatory cell infiltration in the interstitial area in accordance with

 

Table 6: Effect of U. fasciata ethanolic extract and AgNPs / U. fasciata on heart LPO product and SOD activity in doxorubicin-injected rats.

 

Parameters	LPO product (nmole MDA/100mg tissue/hour)	% Change	SOD (mU/100mg tissue)	% Change
Groups
Normal	29.70 ± 1.30a	-	5.30 ± 0.30ab	-
Doxorubicin	52.80 ± 3.90c	77.78	4.40 ± 0.10a	-16.98
Doxorubicin + U. fasciata	37.00 ± 0.90b	-29.92	5.50 ± 0.20b	25.00
Doxorubicin + AgNPs/U. fasciata	33.00 ± 0.40ab	-37.50	5.20 ± 0.40ab	18.18
LSD at the 5% level	2.74		0.42
F- probability	P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

Table 7: Effect of U. fasciata ethanolic extract and AgNPs / U. fasciata on heart GSH content and GPx and GST activities in doxorubicin-injected rats.

 

Parameters	GSH (nmole/100mg tissue)	% Change	GST (U/100mg tissue)	% Change	GPx (mU/100mg tissue)	% Change
Groups
Normal	15.00 ± 0.90bc	-	150.30 ± 2.00c	-	194.50 ± 3.30c	-
Doxorubicin	10.60 ± 0.40a	-29.33	102.50 ± 2.60a	-31.80	181.80 ± 0.90a	-6.53
Doxorubicin + U. fasciata	13.70 ± 0.20b	29.25	114.30 ± 2.60b	11.51	186.70 ± 1.80ab	2.70
Doxorubicin + AgNPs/U. fasciata	14.90 ± 0.50bc	40.57	108.10 ± 2.60ab	5.46	195.30 ± 3.70c	7.43
LSD at the 5% level	0.93		3.13		3.54
F- probability	P<0.001		P<0.001		P<0.001

 

Data are expressed as Mean ± SE; Numbers of detected samples in each group is six; Means, which have different superscript symbol, are significantly different at p<0.05; Percentage changes were calculated by comparing doxorubicin-administered group with normal control and doxorubicin-administered groups treated with U. fasciata ethanolic extract and AgNPs/U. fasciata with doxorubicin-administered control groups.

 

Yilmaz et al. (2006) and Ahmed et al. (2017, 2019, 2020). The improvement in kidney histological architectures by treatment of doxorubicin-injected rats with U. fasciata and AgNPs/U. fasciata is concomitant with amelioration of serum biomarkers of kidney function, suppression of oxidative stress and enhancement of antioxidant defense system in the kidney. Thus, it can be suggested that the improvement in kidney histological integrity and function may be attributed, at least in part, to the attenuation of ROS production and reinforcement of antioxidant defense system mechanism in the kidney.

 

Effects on heart histological changes

Photomicrographs of heart histological sections of normal, doxorubicin-administered groups and doxorubicin-administered groups treated with U. fasciata and AgNPs/U. fasciata were shown in Figure 7 (Photomicrographs 7a-d).

In normal rats, no histopathological alterations were observed and normal histological structure of the myocardial muscle bundles were noticed (Photomicrograph 7a). In doxorubicin-administered rats, there was severe mononuclear inflammatory cells infiltration in the pericardium and between cardiomyocytes in association with necrotic changes (Photomicrograph 7b). These results are in agreement with Chen et al. (2017) and Ahmed et al. (2017, 2019, 2020).

 

After treatment of doxorubicin-administered rats with U. fasciata and AgNPs/U. fasciata, the heart sections showed nearly normal histological architecture and integrity (Photomicrographs 7c and 7d). These improvements in heart histological architecture and integrity were in concomitant with the ameliorations in the elevated serum biomarkers of heart function, suppression in lipid peroxidation and enhancement of the antioxidant defense system. Based on these evidences, it can be elucidated that the amendment of heart histological integrity and function may be ascribed, at least in part, to improvements in lipid peroxidation and the antioxidant defense system mechanisms in the heart.

 

CONCLUSION

 

The biosynthesis of silver nanoparticles using U. fasciata ethanolic extract as reducing agents is proved to be eco-friendly, efficient, rapid and simple method. TEM analysis showed that nanoparticles were produced exhibited large and small spherical particles and small percentages of rod with characteristic absorption peak at 200-400 nm and 600-800 nm in UV-Visible spectrum. In addition, FTIR spectrum revealed the presence of functional bioactive metabolites in algal extract which is responsible for the formation of AgNPs. The chemical constituents, alkaloids, fatty acids, terpernoids, phenolic compounds and aromatic compounds of studied algal extracts were identified by GC-MS; most of these constituents have reducing capability and may be responsible for formation of AgNPs. The results of this study also found that U. fasciata ethanolic extract and AgNPs/U. fasciata have effective preventive action against doxorubicin-induced renal and cardiac toxicities as confirmed by biochemical and histological findings. The AgNPs/U. fasciata was more potent in preventing the doxorubicin-induced kidney and heart toxicities. These preventive effects may be mediated, at least in part, via suppression of oxidative and enhancement of antioxidant defense mechanisms in both kidney and heart.

 

ACKNOWLEDGEMENTS

 

The authors thank Dr. El-Shaymaa El-Nahass, Associate Prof. of Histopathology, Pathology Department, Faculty of Veterinary Medicine, Beni-Suef University, Egypt and Prof. Dr. Rasha R. Ahmed, Professor of Molecular Cell Biology, Cell Biology, Histology and Genetics Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt for help in examining and determining the lesions in the kidney and heart histological stained sections.

 

AUTHOR CONTRIBUTION

 

Asmaa M. Mahmoud: Methodology, Formal analysis, Investigation, Software, Writing-Original Draft, Visualization, Data Curation; Basant M. Mohamed: Conceptualization, Methodology, Formal analysis, Investigation, Writing-Original Draft, Visualization, Validation; Ibraheem B. Mohammed: Conceptualization, Investigation, Writing-Reviewand Editing, Resources, Supervision; Hanan A. Soliman: Conceptualization, Investigation, Writing-Reviewand Editing, Visualization, Supervision; Osama M. Ahmed: Methodology, Formal analysis, Investigation, Writing-Original Draft, Visualization, Data Curation, Writing-Reviewand Editing, Supervision.

Conflict of interest

 

The authors have declared no conflict of interest.

 

REFERENCES

 

• Abdel-Raouf N, Al-Enazi NM, Ibraheem IB (2013). Green biosynthesis of gold nanoparticles using Galaxaura elongata and characterization of their antibacterial activity. Arab. J. Chem., 10(2): S3029-S3039. https://doi.org/10.1016/j.arabjc.2013.11.044

• Abdel-Raouf N, Hozayen WGM, Abd-El-Neem MF, Ibraheem IBM (2017). Potentiality of silver nanoparticles prepared by Ulva fasciata as anti-nephrotoxicity in albino-rats. Egypt. J. Bot., 57(3): 479-494. https://doi.org/10.21608/ejbo.2017.913.1070

• Abirami RG, Kowsalya S (2015). Ulva fasciata nanoparticles characterization and its anticancer activity. World J. Pharm. Pharm. Sci., 4: 1164-1175.

• Ahmed OM, Abdul-Hamid MM, El-Bakry AM, Mohammed HM, Abdel-Rahman F (2019). Effects of green tea infusion and epicatechin on doxorubicin-induced renocardiotoxicity in male Albino rats. Int. J. Pharm. Sci. Res., 10(5): 2210-23.

• Ahmed OM, Ashour MB, Abd El-Fattah AS (2017). The Preventive effects of navel orange peel ethanolic extract and naringin on doxorubicin-induced nephrocardiotoxicity in male albino rats. Indo Am. J. Pharm. Res., 7(7): 109 – 125.

• Ahmed OM, Galay SR, Raslan M, Mostafa MMA (2020). Thyme oil and thymol abrogate doxorubicin-induced nephrotoxicity and cardiotoxicity in Wistar rats via repression of oxidative stress and enhancement of antioxidant defense mechanisms. Biocell, 44(1): 41-53. https://doi.org/10.32604/biocell.2020.08157

• Ajitha B, Reddy YAK, Reddy PS (2015). Green synthesis and characterization of silver nanoparticles using Lantana camara leaf extract. Mat. Sci. Eng. C, 49: 373-381. https://doi.org/10.1016/j.msec.2015.01.035

• Alberto M, Mirko C, Roberta B, Adalberto I, Monica P, Gabriele G, Valentina C, Barbara C, Girolamo M, Rosanna G, Louis RJ, Francesco F, Marco GG (2008). Mesenchymal stem cells protective effect in Adriamycin model of nephropathy. Cell Transplant., 17(10-11): 1157-1167. https://doi.org/10.3727/096368908787236567

• Amaladhas TP, Sivagami S, Devi TA, Ananthi N, Velammal SP (2012). Facile synthesis of silver chloride nanoparticles using marine alga and its antibacterial efficacy. Adv. Nat. Sci. Nanosci. Nanotechnol., 120: 416-420.

• Anand KKH, Mandal BK (2015). Activity study of biogenic spherical silver nanoparticles towards microbes and oxidants. Spectrochim Acta. A. Mol. Biomol. Spectrosc., 135: 639–645. https://doi.org/10.1016/j.saa.2014.07.013

• Anbarasan B, Vennya VM, Niranjana VA, Ramaprabhu S (2013). Optimization of the formulation and in vitro evaluation of chloroquine loaded chitosan nanoparticles using ionic gelation method. J. Chem. Pharm. Sci., 6: 106-112.

• Azab AE, Fetouh FA, Albasha MO (2014). Nephro-protective effects of curcumin, rosemary and propolis against gentamicin induced toxicity in guinea pigs: Morphological and biochemical study. Am. J. Clin. Exp. Med., 2(2): 28-35. https://doi.org/10.11648/j.ajcem.20140202.14

• Babu M, Raja DP, Arockiaraj AA, Vinnarasi J (2014). Chemical constituents and their biologicl acitivity of Ulva lactuca linn. Int. J. Pharm. Drug Anal., 2(7): 595-560.

• Bast EA, Guido RMM, Haenen E, Anna ME, Bruynzeel E, Wim JF, Vijgh V (2007). Protection by flavonoids against anthracycline cardiotoxicity: From chemistry to clinical trials. Cardiovasc. Toxicol., 7: 154–159. https://doi.org/10.1007/s12012-007-0018-0

• Bedi PS, Priyanka S (2012). Effects of Garlic against 7-12, Dimethylbenzanthracene induced toxicity in wistar albino rats. Asian J. Pharm. Clin. Res., 5(4): 0974-2441.

• Belhadj S, Hentati O, Elfeki A, Hamden K (2013). Inhibitory activities of Ulva lactuca polysaccharides on digestive enzymes related to diabetes and obesity. Arch. Physiol. Biochem., 119(2): 81-87. https://doi.org/10.3109/13813455.2013.775159

• Beutler E, Duren O, Kelly BM (1963). Improved method for the determination of blood glutathione. J. Lab Clin. Med., 61(5): 882-888.

• Bhimba BV, Devi JS, Nandhini SU (2014). Green synthesis and cytotoxicity of silver nanoparticles from extracts of the marine macroalgae Gracilaria corticata. Ind. J. Biotechnol., 14: 276-281.

• Brause R, Moeltgen H, Kleinernmanns K (2002). Characterization of laser-ablated and chemically reduced silver colloids in aqueous solution by UV–vis spectroscopy and STM/SEM microscopy. Appl. Phys. B., 75: 711-716. https://doi.org/10.1007/s00340-002-1024-3

• Britto AJD, Sebastian SR, MarySujin R (2012). Antibacterial activity of selective species of Lamiaceae against human pathogens. Ind. J. Nat. Prod. Resour., 3(3): 334-342.

• Burtis CA, Ashwood ER, Bruns DE (2005). Tietz textbook of clinical chemistry and molecular diagnostics, 4th ed. WBSa unders Co.

• Cai W, Fan Y, Jiang Z, Yao J (2010). A highly sensitive and selective resonance scattering spectral assay for potassium ion based on aptamer and nanosilver aggregation reactions. Talanta, 81(4): 1810-1815. https://doi.org/10.1016/j.talanta.2010.03.046

• Cappetta D, Esposito G, Coppini R, Piegari E, Russo R, Ciuffreda LP, De Angelis A (2017). Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction. Br. J. Pharmacol., 174(21): 3696-3712. https://doi.org/10.1111/bph.13791

• Chen P, Hou C, Shibu MA, Day CH, Pai P, Liu Z, Lin T, Viswanadha VB, Kuo C, Huang C (2017). Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts. Environ. Toxicol., 32(2): 679-689. https://doi.org/10.1002/tox.22270

• Devi JS, Bhimba BV (2014). Antibacterial and antifungal activity of silver nanoparticles synthesized using Hypnea muciformis. Biosci. Biotecnol. Res. Asia, 11: 235-238. https://doi.org/10.13005/bbra/1260

• Dhas TS, Kumar VG, Karthick V, Angel KJ, Govindaraju K (2014). Facile synthesis of silver chloride nanoparticles using marine alga and its antibacterial efficacy. Spectrochim. Acta A. Mol. Biomol. Spectrosc., 120: 416–442. https://doi.org/10.1016/j.saa.2013.10.044

• El-Bialy BE, Hamouda RA, Khalifa KS, Hamza HA (2017). Cytotoxic effect of biosynthesized silver nanoparticles on ehrlich ascites tumor cells in mice. Int. J. Pharmacol., 13: 134-144. https://doi.org/10.3923/ijp.2017.134.144

• El-Rafie HM, El-Rafie MH, Zahran MK (2013). Green synthesis of silver nanoparticles using polysaccharides extracted from marine macro algae. Carbohydrate Pol., 96(2): 403–410. https://doi.org/10.1016/j.carbpol.2013.03.071

• Elsherbiny NM, El-Sherbiny M (2014). Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4. Chem. Biol. Interact., 223(5): 102-108. https://doi.org/10.1016/j.cbi.2014.09.015

• Farvin KHS, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK (2004). Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol. Res. 50: 231-236. https://doi.org/10.1016/j.phrs.2004.03.004

• Friedman RB, Young DS (1997). Effects of disease on clinical laboratory tests, 3th ed. AACC press.

• Gürgün C, Ildızlı M, Yavuzgil O Sin A, Apaydın A, Çınar C, Kültürsay H (2008). The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure. Int. J. Cardiol., 123: 102–107. https://doi.org/10.1016/j.ijcard.2006.11.152

• Hamed SM, Abdel-Alim MM, Abdel-Raouf N, Ibraheem IBM (2017). Biosynthesis of silver chloride nanoparticles using the cyanobacterium Anabaena variabilis. Life Sci. J., 14(6): 25-30.

• Hamouda RA, Abd El-Mongy M, Eid KF (2018). Antibacterial activity of silver nanoparticles using Ulva fasciata extracts as reducing agent and sodium dodecyl sulfate as stabilizer. Int. J. Pharmacol., 14(3): 359-368. https://doi.org/10.3923/ijp.2018.359.368

• Hamouda RA, Abd-El-Mongy M, Eid KF (2019). Comparative study between two red algae for biosynthesis silver nanoparticles capping by SDS: Insights of characterization and antibacterial activity. Microb. Pathog., 129: 224-232. https://doi.org/10.1016/j.micpath.2019.02.016

• Henry JB (2001). Diagnosi Cliniche e Gestione di Metodi di Laboratorio, 20th ed., W.B. Saunders Company, Philadelphia.

• Ibraheem IBM, Abd-Elaziz BEE, Saad WF, Fathy WA (2016). Green Biosynthesis of silver nanoparticles using marine red algae Acanthophora specifera and its antimicrobial activity. J. Nanomed. Nanotechnol., 7: 6.

• Javaid A, Oloketuyi SF, Khan MM, Khan F (2018). Diversity of bacterial synthesis of silver nanoparticles. Bio Nano Sci., 8: 43-59. https://doi.org/10.1007/s12668-017-0496-x

• Kabel AM, Alzahrani AA, Bawazir NM, Khawtani RO, Arab HH (2018). Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. J. Infect. Chemother. 24(8): 623-631. https://doi.org/10.1016/j.jiac.2018.03.010

• Kaiserová H, Hartog GJM, Šimůnek T, Schröterová L, Kvasničková E, Bast A (2017). Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. Br. J. Pharmacol., 149: 920-930. https://doi.org/10.1038/sj.bjp.0706930

• Khatri P, Rana JS, Jamdagni P, Sindhu A (2017). Phytochemical screening, GC-MS and FT-IR analysis of methanolic extract leaves of Elettaria Cardamomum. Int. J. Res. Granthaalayha, 5(2): 2394-3629.

• Kokilam G, Vasuki S (2014). Biochemical and phytochemical analysis on Ulva fasciata and Caulerpa taxifolia. Int. J. Pharm. Pharm. Sci. Res., 4(1): 7-11.

• Krishnaraj C, Jagan EG, Rajasekar S, Selvakumar P, Kalaichelvan PT, Mohan N (2010). Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against waterborne pathogens. Colloids Surf. B: Biointerfaces, 76: 50-56. https://doi.org/10.1016/j.colsurfb.2009.10.008

• Langeswaran K, Kumar SS, Gavaskar S (2019). Antioxidant, anti-microbial and anti-cancer effectiveness of marine macro alga Ulva fasciata Delile. Biom. Res., 30(4): 0976-1683. https://doi.org/10.35841/biomedicalresearch.30-19-238

• Mahmoud HM, Hussein UL (2014). Protective effect of sulphated polysaccharides and aqueous extract of Ulva lactuca on N-nitrosodiethylamine and Phenobarbital induced nephrotoxicity in Rats. Int. J. Adv. Res., 2(8): 869-878.

• Manilal A, Sujith S, Kiran GS, Sabarathnam B, Seghal Kiran G, Selvin J, Shakir C, Premnath Lipton A (2010). Antifouling potentials of seaweeds collected from the Southwest coast of India. World J. Agric. Sci., 6: 243-248.

• Mannervik B, Gutenberg C (1981). Glutathione transferase (Human placenta). Meth. Enzymol., 77: 231-235. https://doi.org/10.1016/S0076-6879(81)77030-7

• Margret RJ, Kumaresan S, Ravikumar S (2009). A preliminary study on the anti-inflammatory activity of methanol extract of Ulva lactuca in rat. J. Environ. Biol., 30(5): 899-902.

• Mohajeri M, Sahebkar A (2018). Protective effects of curcumin against doxorubicin induced toxicity and resistance: A review. Crit. Rev. Oncol. Hematol., 122: 30-51. https://doi.org/10.1016/j.critrevonc.2017.12.005

• Mulvaney P (1996). Surface plasmon spectroscopy of nanosized metal particles. Langmuir, 12: 788-800. https://doi.org/10.1021/la9502711

• Nadhe SB, Singh R, Wadhwani SA, Chopade BA (2019). Acinetobactersp. mediated synthesis of AgNPs, its optimization, characterization and synergistic antifungal activity against C. Albicans. J. App. Microbiol., 127: 445-458. https://doi.org/10.1111/jam.14305

• Nagai K, Fukuno S, Otani K, Nagamine Y, Omotani S, Hatsuda Y, Myotoku M, Konishi H (2018). Prevention of doxorubicin-induced renal toxicity by theanine in rats. Pharmacology, 101(3-4): 219-224. https://doi.org/10.1159/000486625

• Nimbal SK, Koti BC (2018). Effect of ethanolic extract of Rosa centifola in doxorubicin-induced myocardial toxicity in albino rats. Ind. Drugs Online. Org. 55(12): 27-33.

• Parveen KS, Lakshmi D (2016). Biosynthesis of silver nanoparticles using red algae, Amphiroa fragilissima and its antibacterial Egypt. J. Bot., 57(3): 93 -100.

• Preuss HG, Jarrel ST, Scheckenbach R, Lieberman S, Anderson RA (1998). Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J. Am. Coll. Nut. 17: 116-123. https://doi.org/10.1080/07315724.1998.10718736

• Pugazhendhi A, Edison TNJI, Velmurugan BK, Jacob JA, Karuppusamy I (2018). Toxicity of doxorubicin (Dox) to different experimental organ systems. Life Sci., 200: 26–30. https://doi.org/10.1016/j.lfs.2018.03.023

• Rahimi Z, Yousefzadi M, Noori A, Akbarzadeh A (2014). Green synthesis of silver nanoparticles using Ulva flexousa from the Persian Gulf, Iran. J. Persian Gulf. 5(15): 9-16.

• Rajadurai M, Prince PSM (2006). Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicol., 228(2-3): 259-268. https://doi.org/10.1016/j.tox.2006.09.005

• Rajeshkumar S, Malarkodi C, Gnanajobitha G, Paulkumar K, Vanaja M, Kannan C, Annadurai G (2012). Seaweed-mediated synthesis of gold nanoparticles using Turbinaria conoides and its characterization. J. Nanostruct. Chem., 3(1): 1-7. https://doi.org/10.1186/2193-8865-3-44

• Rao BV, Boominathan M (2015). Antibacterial activity of silver nanoparticles of seaweeds. Am. J. Adv. Drug Deliv., 3: 296-307.

• Rodeiro I, Olguín S, Santes R, Herrera José A, Pérez Carlos L, Mangas R, Hernández Y, Fernández G, Hernández I, Hernández-Ojeda S, Camacho-Carranza R, Valencia-Olvera A, Javier J (2015). Gas chromatography-mass spectrometry analysis of Ulva fasciata (green seaweed) extract and evaluation of its cytoprotective and antigenotoxic effects. Evid. Based Compl. Alt. Med., pp. 11. https://doi.org/10.1155/2015/520598

• Sabina H, Tasneem S, Samreen KY, Choudhary M, Aliya R (2005). Antileishmanial activity in the crude extract of various seaweed from the coast of Karachi, Pakistan. Pak. J. Bot., 37(1): 163-168.

• Sahayaraj K, Rajesh S (2011). Bionanoparticles: Synthesis and antimicrobial applications. In: Méndez-Vilas, A. (Ed.), Science against microbial pathogens; communicating current research and technological advances. Formatex Research Center, Spain.

• Selvin J, Huxley A, Lipton A (2004). Immunomodulatory potential of marine secondary metabolites against bacterial diseases of shrimp. Aquacultural, 230(1): 241-248. https://doi.org/10.1016/S0044-8486(03)00427-7

• Shahnaz L, Shameel M (2006). Phcochemistry and Bioactivity of some siphonaceous Green Algae from Karachi Coast. Int. J. Phycol. Phycochem., 2(2): 223-228.

• Shiny PJ, Mukhejee A, Chandraskaran N (2013). Marien algae mediated synthesis of Ag nanoparticles and its antibacterial effciency. Int. J. Pharm. Pharm. Sci., 5: 239-241.

• Subash-Babu P, Ignacimuthu S, Prince P (2008). Restoration of altered carbohydrate and Lipid metabolism by hyponid, a herbomineral formulation in streptozotocin induced diabetic rats. Asian J. Biochem., 3(S): 90-98. https://doi.org/10.3923/ajb.2008.90.98

• Swamy MK, Akhtar MS, Mohanty SK, Sinniah UR (2015). Synthesis and characterization of silver nanoparticles using fruit extract of Momordica cymbalaria and assessment of their in vitro antimicrobial, antioxidant and cytotoxicity activities. Spectrochim. Acta A. Mol. Biomol. Spectro., 151: 939–944. https://doi.org/10.1016/j.saa.2015.07.009

• Tappel AL (1978). Glutathione peroxidase and hydroperoxidase. In: Fleischer, S., Packer, L. (Eds.), Methods Enzymol., 52: 506- 513. https://doi.org/10.1016/S0076-6879(78)52055-7

• Tiffany TO, Jansen JM, Burtis CA, Overton JB, Scott CD (1972). Enzymatic kinetic rate and end-point analyses of substrate, by use of a GeMSAEC fast analyzer. Clin. Chem., 18(8): 829-840. https://doi.org/10.1093/clinchem/18.8.829

• Trivedi N, Gupta V, Reddy C, Jha B (2013). Enzymatic hydrolysis and production of bioethanol from common macrophytic green alga Ulva fasciata Delile. Bioresour. Technol., 150: 106-112. https://doi.org/10.1016/j.biortech.2013.09.103

• Valeem E, Shameel M (2006). Fatty acid composition of the class Ulvophyceae (Chlorophyta) from Sindh, Pakistan. Int. J. Phycol. Phycochem., 2(1): 87-92.

• Valeem EE, Rizvi MA, Shameel M (2011). Bioactivity, elementology and fatty acid composition of Ulva fasciata Delile from a rocky ledge of Buleji, Pakistan. Int. J. Phycol. Phycochem., 7(1): 81-90.

• Varely H (1987). Practical clinical biochemistry. In: Gowenlock, A.H., McMurray, J.R., McLauchlan, D.M. (Eds.), London, Heinemann Medical Books, pp. 477-549.

• Vassault A, Grafmeyer D, Naudin G (1986). Protocole de validation de techniques. Document B, Stade 3. Ann. Biol. Clin., 44: 686.

• Wang HQ, Zhang HL, Li XQ, Hua XF, Cao YC, Zhao YD (2007). Purification of denatured bovine serum albumin coated CdTe quantum dots for sensitive detection of silver (I) ions. Anal. Bioanal. Chem., 388(4): 969-974. https://doi.org/10.1007/s00216-007-1277-0

• Wassef EA, Fattah MA, Sayad EI, Sakar EM (2013). Pterocladia (Rhodophyta) and Ulva (Chlorophyta) as feed supplements for European seabass, Dicentrarchus labrax L., fry. J. Appl. Phycol., 25(5): 1369-1376. https://doi.org/10.1007/s10811-013-9995-5

• Witt I, Trendelenburg CJ (1982). Gemeinsame Studie zur Erstellung von Richtwerten für klinisch-chemische Kenngrößen im Kindesalter. Clin. Chem. Clin. Biochem., 20: 235-242. https://doi.org/10.1515/cclm.1982.20.4.235

• Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S (2006). Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology, 218(2–3): 164–171. https://doi.org/10.1016/j.tox.2005.10.015

• Zaid SAA, Hamed NNE, Abdel-Wahab KSE, Abo El-Magd EK, El-Din RAS (2016). Antiviral activities and phytochemical constituents of Egyptian marine seaweeds (CystoseiraMyrica(S.G. Gmelin) C. Agardh and Ulva Lactuca Linnaeus) aqueous extract . Egypt. J. Hosp. Med., 64: 422-429. https://doi.org/10.12816/0029034

• Zhao L, Tao X, Qi Y, Xu L, Yin L, Peng J (2018a). Protective effect of dioscin against doxorubicininduced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biol. 16: 189-198. https://doi.org/10.1016/j.redox.2018.02.026

• Zhao, L., Qi, Y., Xu, L., Tao X, Han X, Yin L, Peng J (2018b). MicroRNA-140-5p aggravates doxorubicininduced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol., 15: 284-296. https://doi.org/10.1016/j.redox.2017.12.013

• Zhou B, Wu LJ, Li LH, Tashiro S, Onodera S, Uchiumi F, Ikejima T (2006). Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. J. Pharmacol. Sci., 102: 387-395. https://doi.org/10.1254/jphs.FPJ06005X

• Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G (2008). Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur. J. Pharmacol., 586(1-3): 244-250. https://doi.org/10.1016/j.ejphar.2008.02.057